BofA/Merrill analyst Steven Valiquette upgraded Align Technology to Buy from Neutral and raised its price target to $193 from $175. The analyst believes the Invisalign growth story is in the early innings as Align has a first-mover advantage and is poised to increase market share. Valiquette believes Align shares are still inexpensive versus the group despite recent strength and said it is one of the fastest growing companies in its peer group.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here